AEQUUS PHARMACEUTICALS INC (AQS.CA) Stock Price, Quote, News and Overview
TSX-V:AQS - TSX Venture Exchange - CA0076361033 - Common Stock - Currency: CAD
AQS.CA Quote, Performance and Key Statistics
TSX-V:AQS (2/19/2025, 7:00:00 PM)
0.01
+0.01 (+100%)
The current stock price of AQS.CA is 0.01 CAD. In the past month the price decreased by -50%. In the past year, price decreased by -87.5%.
AQS.CA Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| BHC.CA | BAUSCH HEALTH COS INC | 1.91 | 3.76B | ||
| TLRY.CA | TILRAY BRANDS INC | N/A | 1.27B | ||
| CRON.CA | CRONOS GROUP INC | N/A | 1.06B | ||
| DHT-UN.CA | DRI HEALTHCARE TRUST | 4.95 | 677.85M | ||
| GUD.CA | KNIGHT THERAPEUTICS INC | N/A | 560.43M | ||
| DHT-U.CA | DRI HEALTHCARE TRUST | 3.5 | 478.55M | ||
| ACB.CA | AURORA CANNABIS INC | N/A | 457.53M | ||
| WEED.CA | CANOPY GROWTH CORP | N/A | 400.51M | ||
| CPH.CA | CIPHER PHARMACEUTICALS INC | 14.04 | 319.88M | ||
| HITI.CA | HIGH TIDE INC | N/A | 299.33M | ||
| TSND.CA | TERRASCEND CORP | N/A | 271.02M | ||
| OGI.CA | ORGANIGRAM HOLDINGS INC | N/A | 229.72M |
Related stock screener links
About AQS.CA
Company Profile
Aequus Pharmaceuticals, Inc. engages in the development and commercialization of alternatives to currently approved drugs. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2015-03-17. The firm is focused on developing and commercializing, differentiated products in ophthalmology. Its pipeline products include PAUL Glaucoma Implant, ZIMED PF, and REV-0100 / ReVision. PAUL is a glaucoma drainage device designed to regulate intraocular pressure in the patient’s eyes and prevent further progression of the disease. PAUL has introduced many design features and unified these into one device and offers a solution for patients with moderate to severe glaucoma. ZIMED PF is the first available multi-dose, preservative free, bimatoprost containing product in Canada. REV-0100 is in preclinical development as a treatment for Stargardt disease. REV-0100 works by reducing levels of a toxic lipid called lipid bisretinoid, which accumulates within the retina in material called lipofuscin.
Company Info
AEQUUS PHARMACEUTICALS INC
Suite 2820, 200 Granville Street
Vancouver BRITISH COLUMBIA V6C 1S4 CA
CEO: Douglas Glen Janzen
Employees: 12
Company Website: https://www.aequuspharma.ca/
Investor Relations: http://www.aequuspharma.ca/en/Investors/index.htm
Phone: 16043367906
AEQUUS PHARMACEUTICALS INC / AQS.CA FAQ
What is the stock price of AEQUUS PHARMACEUTICALS INC today?
The current stock price of AQS.CA is 0.01 CAD. The price increased by 100% in the last trading session.
What is the ticker symbol for AEQUUS PHARMACEUTICALS INC stock?
The exchange symbol of AEQUUS PHARMACEUTICALS INC is AQS and it is listed on the TSX Venture Exchange exchange.
On which exchange is AQS.CA stock listed?
AQS.CA stock is listed on the TSX Venture Exchange exchange.
What is AEQUUS PHARMACEUTICALS INC worth?
AEQUUS PHARMACEUTICALS INC (AQS.CA) has a market capitalization of 1.33M CAD. This makes AQS.CA a Nano Cap stock.
How many employees does AEQUUS PHARMACEUTICALS INC have?
AEQUUS PHARMACEUTICALS INC (AQS.CA) currently has 12 employees.
What are the support and resistance levels for AEQUUS PHARMACEUTICALS INC (AQS.CA) stock?
AEQUUS PHARMACEUTICALS INC (AQS.CA) has a resistance level at 0.01. Check the full technical report for a detailed analysis of AQS.CA support and resistance levels.
Should I buy AEQUUS PHARMACEUTICALS INC (AQS.CA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of AQS.CA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of AQS.CA, evaluating the profitability, health, valuation and growth aspects
- AEQUUS PHARMACEUTICALS INC (AQS.CA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- AEQUUS PHARMACEUTICALS INC (AQS.CA) Sales and EPS estimates to see what analysts future expectations are.
- AEQUUS PHARMACEUTICALS INC (AQS.CA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- AEQUUS PHARMACEUTICALS INC (AQS.CA) Insider and Institutional Ownership to learn about the owners and their transactions.
- AEQUUS PHARMACEUTICALS INC (AQS.CA) Stock Chart to make your own analysis
- AEQUUS PHARMACEUTICALS INC (AQS.CA) Latest news and press-releases to stay up to date.
Does AEQUUS PHARMACEUTICALS INC (AQS.CA) stock pay dividends?
AQS.CA does not pay a dividend.
When does AEQUUS PHARMACEUTICALS INC (AQS.CA) report earnings?
AEQUUS PHARMACEUTICALS INC (AQS.CA) will report earnings on 2025-04-28.
What is the Price/Earnings (PE) ratio of AEQUUS PHARMACEUTICALS INC (AQS.CA)?
AEQUUS PHARMACEUTICALS INC (AQS.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.02).
AQS.CA Technical Analysis
AQS.CA Financial Highlights
Over the last trailing twelve months AQS.CA reported a non-GAAP Earnings per Share(EPS) of -0.02. The EPS increased by 18.14% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -311.85% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |